Elizabeth Folkerd

7.2k total citations · 2 hit papers
90 papers, 5.1k citations indexed

About

Elizabeth Folkerd is a scholar working on Genetics, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Elizabeth Folkerd has authored 90 papers receiving a total of 5.1k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Genetics, 29 papers in Oncology and 27 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Elizabeth Folkerd's work include Estrogen and related hormone effects (51 papers), Cancer Risks and Factors (21 papers) and Hormonal and reproductive studies (16 papers). Elizabeth Folkerd is often cited by papers focused on Estrogen and related hormone effects (51 papers), Cancer Risks and Factors (21 papers) and Hormonal and reproductive studies (16 papers). Elizabeth Folkerd collaborates with scholars based in United Kingdom, United States and France. Elizabeth Folkerd's co-authors include Mitch Dowsett, Robert Luben, Kay‐Tee Khaw, Nicholas J. Wareham, Sheila Bingham, Ailsa Welch, Alison Reid, Johann S. de Bono, Gerhardt Attard and V.H.T. James and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Elizabeth Folkerd

88 papers receiving 4.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Phase I Clinical Trial of a Selective Inhibitor of CYP17, Abiraterone Acetate, Confirms That Castration-Resistant Prostate Cancer Commonly Remains Hormone Driven

2008 666 citations Gerhardt Attard, Alison Reid et al. Journal of Clinical Oncology profile →
Endogenous Testosterone and Mortality Due to All Causes, Cardiovascular Disease, and Cancer in Men

2007 580 citations Kay‐Tee Khaw, Mitch Dowsett et al. profile →

Peers

Countries citing papers authored by Elizabeth Folkerd

Since Specialization

Citations

This map shows the geographic impact of Elizabeth Folkerd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elizabeth Folkerd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elizabeth Folkerd more than expected).

Fields of papers citing papers by Elizabeth Folkerd

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elizabeth Folkerd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elizabeth Folkerd. The network helps show where Elizabeth Folkerd may publish in the future.

Co-authorship network of co-authors of Elizabeth Folkerd

This figure shows the co-authorship network connecting the top 25 collaborators of Elizabeth Folkerd. A scholar is included among the top collaborators of Elizabeth Folkerd based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elizabeth Folkerd. Elizabeth Folkerd is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Palbociclib Combined with Fulvestrant in Premenopausal Women with Advanced Breast Cancer and Prior Progression on Endocrine Therapy: PALOMA-3 Results 2017 ·The Oncologist ·Sibylle Loibl, Nicholas C. Turner, Jungsil Ro, Massimo Cristofanilli, Hiroji Iwata, Seock‐Ah Im, Norikazu Masuda, Sherene Loi, Fabrice André, Nadia Harbeck, Sunil Verma, Elizabeth Folkerd, Kathy Puyana Theall, Justin Hoffman, Ke Zhang, Cynthia Huang Bartlett, Mitch Dowsett	99
2	Principal results of the cancer of the ovary abiraterone trial (CORAL): A phase II study of abiraterone in patients with recurrent epithelial ovarian cancer (CRUKE/12/052) 2016 ·Annals of Oncology ·Susana Banerjee, Lucy Kilburn, Rebecca Bowen, Holly Tovey, Marcia Hall, Stan B. Kaye, Gordon Rustin, Martin Gore, Jennifer McLachlan, Ayoma D. Attygalle, Nina Tunariu, João Paulo da Silveira Nogueira Lima, Peter Chatfield, (unknown), Elizabeth Folkerd, Margaret Hills, Sophie Perry, Gerhardt Attard, Mitch Dowsett, Judith M. Bliss	2
3	Reduced progesterone levels explain the reduced risk of breast cancer in obese premenopausal women: a new hypothesis 2014 ·Breast Cancer Research and Treatment ·Mitch Dowsett, Elizabeth Folkerd	54
4	Combined effects of endogenous sex hormone levels and mammographic density on postmenopausal breast cancer risk: results from the Breakthrough Generations Study 2014 ·British Journal of Cancer ·Minouk J. Schoemaker, Elizabeth Folkerd, Michael E. Jones, (unknown), Steven Allen, Alan Ashworth, Mitch Dowsett, Anthony J. Swerdlow	21
5	A dual-center randomized controlled double blind trial assessing the effect of acupuncture in reducing musculoskeletal symptoms in breast cancer patients taking aromatase inhibitors 2013 ·Breast Cancer Research and Treatment ·Ting Bao, Ling Cai, Jon T. Giles, (unknown), Karineh Tarpinian, (unknown), Michelle Medeiros, Stacie C. Jeter, Nancy Tait, Saranya Chumsri, Deborah K. Armstrong, Ming Tan, Elizabeth Folkerd, Mitch Dowsett, (unknown), (unknown), Vered Stearns	66
6	The Heritability of Mammographic Breast Density and Circulating Sex-Hormone Levels: Two Independent Breast Cancer Risk Factors 2012 ·Cancer Epidemiology Biomarkers & Prevention ·Jajini S. Varghese, Paula L. Smith, Elizabeth Folkerd, Judith Brown, Jean Leyland, Tina Audley, Ruth Warren, Mitch Dowsett, Douglas F. Easton, Deborah J. Thompson	18
7	Premenopausal Mammographic Density in Relation to Cyclic Variations in Endogenous Sex Hormone Levels, Prolactin, and Insulin-like Growth Factors 2009 ·Cancer Research ·Kate Walker, Olivia Fletcher, Nichola Johnson, Ben Coupland, Valerie McCormack, Elizabeth Folkerd, Lorna J. Gibson, Stephen G. Hillier, Jeff M.P. Holly, Sue Moss, Mitch Dowsett, Julian Peto, Isabel dos‐Santos‐Silva	54
8	Abiraterone acetate: the novel application of a CYP450c17 inhibitor to the treatment of both prostate and breast cancer 2009 ·Elizabeth Folkerd, G. Attard, David P. Dearnaley, John W. Hunt, Gal Maier, A. Molina, David Olmos, (unknown), (unknown), Alison Reid, (unknown), (unknown), Mitch Dowsett	1
9	A randomized trial exploring the biomarker effects of neoadjuvant sequential treatment with exemestane and anastrozole in post-menopausal women with hormone receptor-positive breast cancer 2009 ·Breast Cancer Research and Treatment ·Orit Freedman, Eitan Amir, Wedad Hanna, (unknown), F. O’Malley, George Dranitsaris, David E.C. Cole, Sunil Verma, Elizabeth Folkerd, Mitch Dowsett, M. Clemons	12
10	Association between endogenous plasma hormone concentrations and fracture risk in men and women: the EPIC-Oxford prospective cohort study 2009 ·Journal of Bone and Mineral Metabolism ·Andrew Roddam, Paul N. Appleby, Rachel Ε. Neale, Mitch Dowsett, Elizabeth Folkerd, Sarah Tipper, Naomi E. Allen, Timothy J. Key	24
11	Phase I Clinical Trial of a Selective Inhibitor of CYP17, Abiraterone Acetate, Confirms That Castration-Resistant Prostate Cancer Commonly Remains Hormone Driven breakdown → 2008 ·Journal of Clinical Oncology ·Gerhardt Attard, Alison Reid, Timothy A. Yap, Florence I. Raynaud, Mitch Dowsett, S. Settatree, Mary Barrett, Christopher Parker, Vanessa Martins, Elizabeth Folkerd, J. W. Clark, Colin S. Cooper, Stan B. Kaye, David P. Dearnaley, Gloria Lee, Johann S. de Bono	666
12	Selective inhibition of CYP17 with abiraterone acetate is well tolerated and results in a high response rate in castration-resistant prostate cancer (CRPC) 2007 ·Molecular Cancer Therapeutics ·Gerhardt Attard, Alison Reid, Rajesh Kumar Sinha, R. Molife, Florence I. Raynaud, Mitch Dowsett, Mary Barrett, Emilda Thompson, Timothy A. Yap, S. Settatree, Vanessa Martins, Christopher Parker, David P. Dearnaley, Elizabeth Folkerd, Gloria Lee, Johann S. de Bono	1
13	Caution: Vaginal estradiol appears to be contraindicated in postmenopausal women on adjuvant aromatase inhibitors 2006 ·Annals of Oncology ·Anne Kendall, Mitch Dowsett, Elizabeth Folkerd, Ian Smith	196
14	Polymorphisms in the CYP19 Gene May Affect the Positive Correlations between Serum and Urine Phytoestrogen Metabolites and Plasma Androgen Concentrations in Men 2005 ·Journal of Nutrition ·Yen-Ling Low, James I. Taylor, Philip B. Grace, Mitch Dowsett, Elizabeth Folkerd, Deborah Doody, Alison M. Dunning, Serena Scollen, Angela A. Mulligan, Ailsa Welch, Robert Luben, Kay‐Tee Khaw, Nick Day, Nicholas J. Wareham, Sheila Bingham	43
15	The biology of steroid hormones and endocrine treatment of breast cancer 2005 ·The Breast ·Mitch Dowsett, Elizabeth Folkerd, Deborah Doody, Ben P. Haynes	36
16	Urinary 6‐sulfatoxymelatonin levels and their correlations with lifestyle factors and steroid hormone levels 2005 ·Journal of Pineal Research ·Eva Schernhammer, Candyce H. Kroenke, Mitch Dowsett, Elizabeth Folkerd, Susan E. Hankinson	82
17	Aldosterone synthase gene (CYP11B2) C-344T polymorphism, plasma aldosterone, renin activity and blood pressure in a multi-ethnic population 2004 ·Journal of Hypertension ·Antonio Barbato, Paola Russo, Alfonso Siani, Elizabeth Folkerd, Michelle A. Miller, Antonella Venezia, Claudia Grimaldi, Pasquale Strazzullo, Francesco P. Cappuccio	64
18	Deficits in plasma oestradiol measurement in studies and management of breast cancer 2004 ·Breast Cancer Research ·Mitch Dowsett, Elizabeth Folkerd	62
19	Polymorphisms Associated With Circulating Sex Hormone Levels in Postmenopausal Women 2004 ·JNCI Journal of the National Cancer Institute ·Alison M. Dunning, Mitch Dowsett, Catherine S. Healey, Louise Tee, Robert Luben, Elizabeth Folkerd, Karen Novik, Livia Kelemen, Soshiro Ogata, Paul D.P. Pharoah, Douglas F. Easton, N. E. Day, Bruce A.J. Ponder	278
20	An automated technique for the simultaneous determination of cations in nanoliter volumes 1999 ·Kidney International ·(unknown), Jonathan M. Slater, Robert J. Unwin, S. J. Walter, Elizabeth Folkerd	11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact